https://www.selleckchem.com/pr....oducts/caspofungin-a
INTRODUCTION Influenza in hospitalized intensive care unit (ICU) patients with respiratory failure is associated with 25% mortality, despite timely oseltamivir treatment. A systematic review of randomized controlled trials (RCTs) was conducted to evaluate the efficacy and safety of alternative neuraminidase inhibitor (NAI) regimens compared to standard of care in patients hospitalized for H1N1, H3N2, or B influenza. METHODS The Cochrane collaboration searching methods were followed in Cochrane Library, PubMed, and Web of Sci
Like
Comment
Share
